BICO Group AB (publ) (OTCMKTS:CLLKF) Shares Down 4.8% – Time to Sell?

BICO Group AB (publ) (OTCMKTS:CLLKF – Get Free Report)’s stock price dropped 4.8% during trading on Wednesday. The company traded as low as C$2.15 and last traded at C$2.15. 340 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 7,950 shares. The stock had previously closed at C$2.26.

BICO Group AB (publ) Stock Performance

The business has a 50 day moving average of C$1.81 and a 200 day moving average of C$1.93.

BICO Group AB (publ) Company Profile

(Get Free Report)

BICO Group AB (publ), formerly known as CELLINK AB, is a biotechnology company specializing in the development and commercialization of tools and solutions for life science research. The company’s core offerings include advanced 3D bioprinters, proprietary bioinks, microfluidic devices and cell analytics instruments. These technologies are designed to accelerate drug discovery, tissue engineering and personalized medicine by enabling researchers to create and analyze complex biological models in vitro.

In addition to its flagship bioprinting platforms, BICO provides a broad portfolio of consumables and software that support end-to-end workflows for cell culture and bioprocessing.

Further Reading

• Five stocks we like better than BICO Group AB (publ)
• Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
• Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
• Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
• Oil May Be Stronger Than It Looks—And Diamondback Is on Sale

Receive News & Ratings for BICO Group AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BICO Group AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.